FFR Case Review With Drs. William F. Fearon, Morton J. Kern and Peter Ver
Lee Among the Highlights
WILMINGTON, Massachusetts, October 8 /PRNewswire/ -- The use of fractional flow reserve (FFR) for optimizing patient outcomes is the topic of multiple sessions at this year's Transcatheter Cardiovascular Therapeutics symposium, TCT 2008, which will take place Oct. 12-17 in Washington, D.C.
Radi Medical Systems, the first company to develop systems that calculate FFR with the physiologic assessment of targeted lesions, is sponsoring a breakfast session, "Intervention Under Pressure: Discovering the best way with FFR," at 7 a.m. EDT on Tuesday, Oct. 14, in room 150 B at the Washington Convention Center. During the session, William F. Fearon, M.D., of Stanford University, will discuss FFR measurement in multi vessel disease, Morton J. Kern, M.D., of the University of California, Irvine, will speak about FFR measurement in challenging lesion subsets, and Peter Ver Lee, M.D., of the Eastern Maine Medical Center, will provide an overview of FFR measurement in private practice.
Following the session, data from the study titled "Fractional flow reserve vs. Angiography for Multivessel Evaluation" (FAME) will be presented by Dr. Fearon and Nico Pijls, M.D., Ph.D., in the Main Arena at 11:45 a.m. EDT. FAME is the world's first randomized, prospective, multicenter trial to compare clinical outcomes and the cost-effectiveness of a physiologic-guided percutaneous coronary intervention (PCI) strategy to an angiographic-guided one in patients with multi vessel coronary artery disease
"We are excited to discuss topics pertaining to fractional flow reserve
measurement, a few hours before data from the FAME study is presented in
the Main Arena," said Jason Rudy, Director of Marketing of Radi Medical
Systems Inc. "We anticipate that these will be two engaging sessions that
educate about the benefits of FFR use in today's cathlab.
|SOURCE Radi Medical Systems AB|
Copyright©2008 PR Newswire.
All rights reserved